Search results

The Department of Health has agreed that the February Drug Tariff Part VIIIA reimbursement prices for the following items will be: Buspirone 5mg tablets £17.50 Leflunomide 10mg tablets £7.79 Leflunomide 20mg tablets £9.03 Valsartan 40mg…

The Department of Health has agreed that the March Drug Tariff Part VIIIA reimbursement price for the following items will be: Buspirone 5mg tablets £16.50 Leflunomide 10mg tablets £7.76 Leflunomide 20mg tablets £8.90 Nitrofurantoin 100mg…

The Department of Health has agreed that the April Drug Tariff Part VIIIA reimbursement price for the following items will be: Clindamycin 150mg capsules £4.85 Flecainide 50mg tablets £11.57 Leflunomide 20mg tablets £8.16 and not as printed in…

Drug Tariff Part VIIA: Quality Payments Scheme (England): Correction Contractors should be made aware that paragraph 2.1 of Part VIIA in the October Drug Tariff should read: “There will be one review on 15 February 2019, at which quality payments…

The Department of Health and Social Care with the Pharmaceutical Services Negotiating Committee’s agreement is maintaining CPCF funding for 2018/19  at the same level as last year, i.e. £2.592 billion. In order to deliver this level of funding the…

Guidance for manufacturers and suppliers of medicines, oxygen and appliances. This includes: updating us on product details and price information through Medicines Data - dm+d access to the home oxygen therapy application information on…

We have recently noticed a rise in items that are being referred back to contractors for the reason code RB2B: ‘The order/endorsement is incomplete. The presentation must be present.’ This commonly occurs with handwritten prescriptions. If you…

Since February 2024, a licensed version of Azathioprine 50mg/5ml oral suspension became available. Therefore, for prescriptions dispensed in February and March 2024: where there is an endorsement for the licensed product, then reimbursement will…

We're currently working to migrate a number of reports from ISP to ePACT2 and the new public facing portal ‘Catalyst’.  We're removing access to a number of reports currently viewed via ISP on Friday 11 January 2019 in preparation of the migration…

We have received a number of enquiries from contractors who have endorsed an incorrect product and pack size, leading to referred backs and delays in payment. When dispensing a drug not listed in Part VIII of the Drug Tariff, you must endorse…